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Abstract
Background: Thyroid cancer is a common malignant disease of the endocrine system with increasing incidence
rates over the last few decades. In this study, we sought to analyze the possible association of 45 single nucleotide
polymorphisms (SNPs) with thyroid cancer in a population from Rio Grande do Norte, Brazil.
Methods: Based on histological analysis by a pathologist, 80 normal thyroid specimens of tissue adjacent to thyroid
tumors were obtained from the biobank at the Laboratory of Pathology of Liga Norte Riograndense Contra o Câncer,
Natal, RN. Patient samples were then genotyped using the MassARRAY platform (Sequenon, Inc) followed by statistical
analysis employing the SNPassoc package in R program. The genotypic frequencies of all 45 SNPs obtained from the
International HapMap Project database and based on data from the ancestral populations of European and African
origin were used to compose the control study group.
Results: In our study, the following 9 SNPs showed significant differences in their frequency when comparing the study
and control groups: rs3744962, rs258107, rs1461855, rs4075022, rs9943744, rs4075570, rs2356508, rs17485896, and rs2651339.
Furthermore, the SNPs rs374492 C/T and rs258107 C/T were associated with a relative risk for thyroid carcinoma of 3.78 (p=
6.27 × 10e−5) and 2.91 (p= 8.27 × 10e−5), respectively, after Bonferroni’s correction for multiple comparisons.
Conclusions: These nine polymorphisms could be potential biomarkers of predisposition to thyroid carcinoma
in the population from Rio Grande do Norte. However, complementary studies including a control group with
samples obtained from healthy subjects in Rio Grande do Norte state, should be conducted to confirm these results.
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Background
Thyroid cancer (TC) is the most common endocrine
malignancy, and its incidence rate has been increasing
noticeably for decades [1]. Hence, if the observed trends
are maintained, TC will replace colorectal cancer as the
fourth leading cancer diagnosis in the United States by
2030 [2]. Such an increase is likely due to improved
diagnosis, and largely or completely reflects the over diag-
nosis of indolent disease [3]. According to the Brazilian
National Cancer Institute, about 6.960 new cases of TC
were expected in Brazil in 2016 [4]. The state of Rio
Grande do Norte, located in the northeast region of Brazil,
presents the fourth highest estimated TC incidence rate in
the country, which corresponds to 130 cases per 100,000
women and 30 cases per 100,000 men [4].
The thyroid gland is mainly composed of two cell
types: follicular cells and parafollicular cells. Based on
histological and clinical parameters, follicular cell-
derived carcinomas, which correspond to more than
90% of thyroid carcinomas, are typically divided into well
differentiated, poorly differentiated, and undifferentiated
(or anaplastic) carcinomas. Well differentiated thyroid
carcinomas (WDTC) are further subdivided histologically
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as papillary thyroid carcinoma and follicular thyroid
carcinoma, which correspond to 80% and 10% of thyroid
carcinomas, respectively [5]. Both these carcinomas can
progress to poorly differentiated carcinoma or completely
lose differentiation, giving rise to anaplastic carcinoma [6].
On the other hand, parafollicular cell-derived medullary car-
cinoma accounts for about 5% of thyroid carcinomas [5, 7].
The recent progress in understanding the molecular
pathogenesis of TC has paved the way for developing
more effective treatment strategies. This has mainly re-
sulted from identification of numerous genetic and epi-
genetic changes including mutations, gene copy-number
gain, gene translocation, and aberrant gene methylation,
resulting in alterations of the signaling pathways in-
volved in regulating cell proliferation and survival, such
as the MAPK and PI3K–AKT pathways among others,
which are reshaping TC medicine [8, 9]. In addition, it is
widely accepted that genetic predisposition to WDTC is
expected to have common low-penetrance and rare
moderate-penetrance genetic variants interacting with
each other and with the environment determining indi-
vidual susceptibility [10].
Recent high-throughput genotyping (GWAS) studies
sought to identify single nucleotide polymorphisms
(SNPs) associated with increased risk of thyroid tumori-
genesis and to better explain the role of genetic varia-
tions in predisposition to TC [10–22]. However, some
studies have demonstrated contradictory results, prob-
ably due to genetic diversity both within and among
populations. This observation raises the question of
whether a new panel of SNPs could be used as potential
predisposition markers for TC.
Therefore, this study aimed to investigate whether the
selected SNPs could be associated with predisposition to
TC in patients diagnosed with this neoplasia in the state
of Rio Grande do Norte. Considering that the population
of this region is characterized by a marked ethnic mix-
ture, this study may significantly contribute to elucidat-
ing the molecular basis underlying both predisposition




In this retrospective study, 80 tumor formalin-fixed paraffin-
embedded (FFPE) samples of tissue adjacent to thyroid
tumors were selected from patients diagnosed with thyroid
cancer at the Laboratory of Pathology, Hospital Liga Norte
Riograndense Contra o Câncer (Natal, Brazil) between 2003
and 2011. Among these 80 cases, 77 had papillary thyroid
carcinoma and 3 had follicular thyroid carcinoma, as
confirmed based on histological analysis by a pathologist.
Ten 20-μm sections were cut from blocks containing non-
tumor tissue using a Rotary Microtome YD-335 (ANCAP,
São Paulo, Brazil). Samples were placed in 1.5 mL micro-
tubes at room temperature until processing. For each patient
sample, a unique High Profile 818 disposable blade (Leica
Microsystems GmbH, Wetzlar, Germany) was used to avoid
contamination of genomic DNA.
The control group was obtained from the International
HapMap project and consisted of genotype data from
180 healthy individuals: 90 with European ancestry and
90 with African ancestry (HapMap Genome Browse,
release#24 Phase 1 & 2 - full dataset).
This research was approved by the Ethics Committee
in Research from Hospital Liga Norte Riograndense
Contra o Câncer (protocol number 558788).
DNA extraction
FFPE tissue samples were deparaffinized with 2.4 mL of
xylene (2 × 5 min at 14,000 rpm) and washed with 2.4 mL
of 100% ethanol (2 × 5 min at 14,000 rpm). DNA was then
isolated using the QIAamp® DNA FFPE Tissue Kit (QIA-
GEN, Valencia, EUA), according to the manufacturer’s
instruction. DNA quantification was performed using the
NanoDrop ND-1000 spectrophotometer. DNA samples
were diluted to a final concentration of 20 ng/μL.
SNP selection
A panel of 45 SNPs was selected through previous studies
performed at the Genotyping National Center (CEGEN)
in Santiago de Compostela – Spain (www.usc.es/cegen/),
coordinated by Dr. Angel Carracedo, Professor of the
Faculty of Medicine, University of Santiago de Compostela
(USC) [10].
Genotyping
SNP genotyping of the case group was performed using
the MassARRAY SNP genotyping system (Agena Bio-
science San Diego, EUA) according to manufacturer’s
instructions at the National Genotyping Center (CEGEN),
on a panel of 45 SNP assays. The primers for amplification
and extension were designed using the Extend Primer
Assay Design software v4. Sequenom iPLEX GOLD chem-
istry was used for locus-specific amplification, followed by
a single-base primer extension reaction, which generated
products of different masses that were quantitatively ana-
lyzed using MALDI-TOF mass spectrometry. The result-
ing data were analyzed using TyperAnalyzer software v 4,
followed by manual inspection of the spectra by trained
personnel [23]. All assays were performed in 384-well
plates, including negative controls and a trio of Coriell sam-
ples (Na10830, Na10831, and Na12147) for quality control.
Statistical analysis
Statistical tests were performed using the SNPassoc
function in the R software v2.14.1 statistical package (R
Development Core Team, 2006) [24]. For each SNP,
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associations were assessed by applying logistic regression
to estimate the odds ratios (ORs) with 95% confidence
intervals and P values. A P value <0.05 was considered
statistically significant.
Results
Eighty TC patients from Brazil were genotyped for 45
SNPs, to identify potential molecular markers of predis-
position to this neoplasia. Among all the patients stud-
ied, 77 were diagnosed with papillary thyroid carcinoma
and 3 with follicular thyroid carcinoma. The age of one
patient was not determined, and the staging, location, and
size of tumor were also not determined in some patients.
Among the 80 patients, 61 lymph node metastases were
not evaluated. These data are shown in Table 1.
The allelic frequencies of 45 SNPs were analyzed and the
minimum cutoff value for missing genotypes was defined
as 10%. The allelic composition, allele major frequency and
the p value for the Hardy-Weinberg equilibrium (HWE) of
each SNP are shown in Table 2. Of these 45 SNPs, 11 were
excluded from the study because they were not in the
HWE (p < 0.05). The allelic frequencies from the Brazilian
population were compared with those available in the
HapMap database for 180 individuals of European and
African ancestry, which constituted the control group.
The association analysis between patients and control
groups for SNPs that showed a p-value greater than 0.05
for Hardy-Weinberg equilibrium is shown in Table 3 and
Additional file 1: Table S1, which classify SNPs according
to the inheritance model: dominant (AA/Ab + bb); reces-
sive (AA +Ab/bb); over dominant (Ab/AA + bb) and co-
dominant (AA/Ab/bb). As observed, 7 SNPs showed sig-
nificant expression in the co-dominant model (rs1461855,
rs2356508, rs258107, rs3744962, rs4075022, rs4075570,
and rs9943744), 5 in the dominant model (rs1461855,
rs258107, rs3744962, rs4075022, and rs9943744), 4 in the
recessive model (rs1461855, rs2651339, rs4075570, and
rs9943744) and 6 in the over dominant model (rs1461855,
rs17485896, rs2356508, rs258107, rs3744962, and
rs4075022). Most SNPs presented statistical significance
under more than one model of inheritance. Furthermore,
the SNPs rs374492 C/T and rs258107 C/T were associated
with a relative risk for TC of 3.78 (p = 6.27 × 10e−5) and
2.91 (p = 8.27 × 10e−5), respectively after Bonferroni’s
correction for multiple comparisons.
Figure 1 shows the results for logistic regression ana-
lysis of significant SNPs according to the model of inher-
itance, their respective odds ratios (OR), and p-values.
Among the 9 SNPs analyzed (rs1461855, rs17485896,
rs2356508, rs258107, rs2651339, rs3744962, rs4075022,
rs4075570, and rs9943744), 7 showed OR values greater
than 1, meaning that those alleles represent a risk for
thyroid cancer development. In particular, the SNP
rs3744962 showed the greatest risk with an OR value of
3.78. On the other hand, 2 SNPs (rs1461855 and
rs2356508) were associated with a protective effect, with
OR values less than 1.
Discussion
The genetic ancestry profile of Brazilian population sam-
ples have been largely investigated in the last decades,
mainly using uniparental inherited markers such mito-
chondrial DNA and Y-chromosome polymorphisms
[25–29], as well as autosomal STR markers [30, 31]. In
addition, some studies used ancestry informative markers
Table 1 Clinical and pathological characteristics of patients
enrolled in this study
Variables N %
Gender Female 69 86%
Male 11 14%
Total 80 100%
Classification Papillary 77 96%
Follicular 3 4%
Total 80 100%
Age (years) < 45 38 48%
≥ 45 41 52%
Uninformed 1 1%
Total 80 100%






Tumor size (cm) ≤ 2 55 72%
2 < size ≤4 18 23%
> 4 4 5%
Uninformed 3 4%
Total 77 100%




Extrathyroidal extension Yes 49 61%
No 31 39%
Total 80 100%
Histological subtype Classic 64 80%
Follicular 11 14%
Encapsulated follicular 3 4%
Oxyphilic 2 2%
Total 80 100%
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such as SNPs and insertion/deletion polymorphisms have
been used to estimate genetic ancestry [32–36].
All these previous studies conclude that the genetic
ancestry of the Brazilian population is widely heteroge-
neous and is characterized by extensive admixture from
three different ancestral roots: Amerindians, Europeans,
and Africans. Furthermore, the composition of the
Brazilian population ancestry follows a clear trend
related to historical facts [37, 38]. European colonization
of Brazil showed successive migration waves, starting
with the arrival of around 500,000 Portuguese men
between the years 1500 and 1800, when they met the
local Amerindian population. Portuguese-Amerindian
admixture began soon after arrival of the first colonizers.
Simultaneously, about 4 million Africans were compulsor-
ily introduced into Brazil as slaves until the mid-
eighteenth century, providing the second major ethnic
contribution to the Brazilian population. Later, other
waves of immigration to Brazil occurred, mainly from
Italy, Portugal, Spain, Germany, Syria, Lebanon, and Japan,
adding even more complexity to the already multi-ethnic
highly admixed Brazilian population [37, 38].
Brazil is the fifth largest country in the world and is
divided into five geographical regions. In all these
regions, the European ancestry is predominant with pro-
portions ranging from 60.6% in the Northeast to 77.7%
in the South [34, 39–42]. The African and Amerindian
contributions to the population genetic background vary
according to the region. The African ancestry proportion
was the second largest in the Northeast (30.3%),
followed in decreasing order by the Southeast, South,
and North. On the other hand, populations in the North
consist of a significant proportion of Amerindian ances-
try, while remaining relatively uniform in other regions.
Table 2 SNPs evaluated according to Hardy-Weinberg equilibrium.
The allele information were showed as Reference allele/Risk allele.
P < 0.05 in bold. SNPs. Single nucleotide polymorphism; MAF:
Minor Alleles frequency; HWE: Hardy-Weinberg Equilibrium. MAF
YRI Minor Alleles frequency of population African; MAF EUR Minor
Alleles frequency of European according with 1000 genomes project






rs11749656 C/A 2.4 1.0000 3.1 – 5.0
rs1254167 G/C 8.7 1.0000 2.3 11.1 10.1
rs17026194 G/A 1.9 1.0002 1.2 5.5 –
rs17821714 G/A 3.7 1.0003 0.8 – 6.5
rs4245211 A/G 34.9 0.8885 5.8 40.7 26.7
rs6507639 T/G 7.1 1.0000 2.3 11.1 7,5
rs2910164 G/C 34.5 0.8899 1.9 – –
rs6578493 A/C 19.9 0.8439 4.2 22.6 22.7
rs6825379 A/G 14.5 0.6189 3.1 30.5 5.0
rs664677 T/C 35.7 1.0000 4.2 19.4 44.4
rs10790373 C/T 27.8 0.7458 10 30.0 20.7
rs2651339 A/C 48.2 0.5273 4.6 44.4 48.4
rs566309 C/T 8.6 0.7043 1.5 11.1 9.6
rs2356508 C/A 8.7 1.0000 2.3 10.6 7.5
rs3744962 T/C 7.3 0.6285 2.3 0.9 8.5
rs17485896 T/C 22.7 0.4762 2.7 8.3 34.8
rs11856964 A/C 12.2 0.5525 1.9 14.3 13.1
rs1158257 C/T 46.9 0.7065 1.5 39.8 48.9
rs9943744 C/T 46.7 0.5285 2.3 28.2 42.9
rs7028661 G/A 31.0 0.3770 3.8 15.7 35.3
rs258107 C/T 27.9 0.4344 3.5 17.1 30.3
rs9993140 G/A 3.9 0.3222 2.3 15.2 1.5
rs31872 T/C 22.7 0.1938 8.5 8.8 33.8
rs11720059 G/A 6.0 0.2120 3.5 – 9.0
rs949908 T/A 47.6 0.1593 5.8 45.3 45.4
rs965513 G/A 29.1 0.2244 1.5 13.4 35.5
rs4075022 T/C 28.2 0.0827 5.8 6.0 43.4
rs12137541 G/A 22.4 0.0701 2.3 16.6 27.7
rs1801516 G/A 12.3 0.0869 1.2 – 18.1
rs1499008 G/A 37.2 0.1066 2.7 22.2 47.4
rs1461855 T/A 20.2 0.0799 1.9 45.8 8.0
rs2839582 T/C 40.7 0.0671 3.1 47.6 29.2
rs4075570 G/A 49.2 0.1263 5.0 39.3 38.8
rs7037324 G/A 26.5 0.0504 3.5 7.4 39.3
rs6983267 G/T 31.0 0.0236 6.9 2.7 48.4
rs4698951 T/C 26.8 0.0103 1.2 37.9 6.0
rs17072086 T/C 15.9 0.0038 1.9 0.4 22.7
rs2284734 G/A 46.3 0.0027 1.2 20.8 33.8
rs2997312 G/A 28.1 0.0079 2.3 43.9 12.6
Table 2 SNPs evaluated according to Hardy-Weinberg equilibrium.
The allele information were showed as Reference allele/Risk allele.
P < 0.05 in bold. SNPs. Single nucleotide polymorphism; MAF:
Minor Alleles frequency; HWE: Hardy-Weinberg Equilibrium. MAF
YRI Minor Alleles frequency of population African; MAF EUR Minor
Alleles frequency of European according with 1000 genomes project
(Continued)






rs10912963 G/C 40.9 0.0059 4.6 17.5 44.9
rs12206214 G/A 28.8 0.0056 3.1 17.5 42.9
rs13447450 C/T 17.4 0.0007 1.5 0.9 37.8
rs162270 G/T 15.1 0.0002 2.7 – –
rs9937860 T/G 15.1 0.0002 3.5 16.6 12.1
rs944289 C/T 38.1 0.00004 1.2 12.9 39.3
The allele information were showed as Reference allele/Risk allele. P < 0.05 in
bold. SNPs. Single nucleotide polymorphism; MAF Minor Alleles frequency,
HWE Hardy-Weinberg Equilibrium. MAF YRI Minor Alleles frequency of
population African; MAF EUR Minor Alleles frequency of European according
with 1000 genomes project
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In particular, the northeast region of Brazil where the
state of Rio Grande do Norte is located, presents the
highest African ancestry contribution in the country
ranging from 18.6 to 56.8% [34, 39–43].
The heterogeneity and admixture of Brazilians consti-
tutes an important issue to be considered in genetic
association studies [34]. Besides, it has important clinical
implications for the design and interpretation of clinical
trials and genetic counseling. Because of its heterogeneous
Amerindian, European, and African ancestral roots, the
Brazilian population has been considered an important
model for population genetics. In this context, our work
aimed to genotype and assess the allele frequency of 45
SNPs to identify potential molecular markers of predis-
position to TC in the population of Rio Grande do Norte,
compared to the frequency of these alleles in European
and African populations.
An extensive review of literature showed that consider-
able progress towards understanding complex diseases has
been made in recent years due to development of high-
throughput genotyping technologies [44]. Furthermore,
several GWAS studies have identified SNPs associated with
many complex diseases or traits. In the particular case of
TC, genetic risk loci are under characterization in terms of
allelic variants or genes responsible for association with the
disease, as well as the affected biological pathway and the
main cell type driving its pathology [45].
In this regard, a growing number of studies have identi-
fied several SNPs associated with TC risk [10–17, 19, 20,
22, 46–49]. In the study by Gudmundsson and collabora-
tors [46], a GWAS analysis was performed in a population
from Iceland and showed a strong association of SNPs
rs965513 and rs944289 with papillary and follicular
thyroid cancer. Furthermore, rs944289 and rs965513 cor-
respond to gene variants of Thyroid transcription factor 1
and 2, respectively, and both TC risk alleles were associ-
ated with low concentrations of thyroid stimulating
hormone, and SNP rs965513 was associated with low
thyroxin concentration and high triiodothyronine concen-
tration [46]. Later, the same group found that rs966423,
rs2439302, and rs116909374 variants were also associated
with TC [11].
The association of rs944289 and rs965513 with TC
risk was also shown in genetic studies conducted in
Asian populations [14, 50, 51]. Additionally, Wang
and collaborators [48] observed that SNPs rs966423
and rs2439302, previously reported to be associated
with TC in European populations, were confirmed as
risk factors in the Chinese population.
Similarly, another study has demonstrated that SNPs
rs2910164, rs965513, rs1867277, rs6983267, and rs944289
showed a significant association with TC risk in patients
from the United Kingdom [12]. Furthermore, according to
Jendrzejewski [52], the SNP rs944289 can predispose to
Table 3 Association analysis of thyroid carcinoma and SNPs
under different genetic inheritance model. The SNPs rs258107
and rs3744962 remained significant after the correction of
multiple Bonferroni test. P < 0.05 in bold. Dominant, AA/Ab + bb;
Recessive, AA + Ab/bb; Overdominant, Ab/AA + bb; e Co-
dominant, AA/Ab/bb; SNP,single nucleotide polymorphism
Genetic Inheritance Model
SNP Codominant Dominant Recessive Overdominant
rs3744962 0.00004 0.00006 0.08869 0.00037
rs258107 0.00011 0.00002 0.19808 0.00038
rs9943744 0.00832 0.02203 0.00586 0.74091
rs1461855 0.01031 0.00866 0.02415 0.09031
rs4075022 0.01321 0.00572 0.05205 0.11500
rs2356508 0.01968 0.19642 0.08636 0.05817
rs4075570 0.02358 0.04191 0.01359 0.65497
rs2651339 0.03293 0.83057 0.01936 0.02445
rs17821714 0.13175 – – –
rs17485896 0.13440 0.37340 0.14229 0.11092
rs7037324 0.23323 0.10739 0.95633 0.10064
rs6825379 0.27488 0.85283 0.18560 0.45379
rs949908 0.28475 0.21267 0.64497 0.12649
rs965513 0.32316 0.13310 0.56678 0.23804
rs2910164 0.39720 0.64797 0.17431 0.68458
rs1158257 0.42592 0.32289 0.25281 0.93547
rs566309 0.43874 0.24447 1 0.20038
rs12137541 0.44455 0.25309 0.89503 0.20454
rs17026194 0.45068 – – –
rs7028661 0.48507 0.24038 0.51989 0.43616
rs664677 0.51326 0.24855 0.67168 0.38747
rs1254167 0.55835 0.27937 1 0.38631
rs6578493 0.57504 0.92152 0.30054 0.74190
rs11856964 0.59493 0.35849 0.55739 0.42250
rs1801516 0.70738 – – –
rs11749656 0.71229 – – –
rs1499008 0.75451 0.69100 0.66191 0.46602
rs2839582 0.78512 0.60386 0.53001 0.99911
rs4245211 0.78865 0.80208 0.59695 0.55160
rs31872 0.81039 0.85747 0.51785 0.86577
rs11720059 0.84074 0.82070 0.55916 0.95422
rs10790373 0.89519 0.88354 0.70565 0.71643
rs6507639 1 0.93703 1 0.96945
The SNPs rs258107 and rs3744962 remained significant after the correction of
multiple Bonferroni test. P < 0.05 in bold. Dominant, AA/Ab + bb; Recessive,
AA + Ab/bb; Overdominant, Ab/AA + bb; e Co-dominant, AA/Ab/bb; SNP single
nucleotide polymorphism;
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papillary thyroid carcinoma through deregulation of PTCSC3
expression, which acts as a tumor suppressor.
A correlation study between Forkhead box E1 (FOXE1)
gene variants rs894673, rs1867277, and rs3758249, and
histopathological features of TC, suggested that FOXE1
variations generate a higher risk for poor histopathological
features in papillary thyroid carcinoma [17]. In addition,
Mancikova et al., [10] showed an association between
SNPs rs7028661 and rs7037324, located near the FOXE1
locus, and TC risk. Moreover, the rare alleles of three
SNPs (rs2997312, rs10788123 and rs1254167) showed
suggestive evidence of association with higher risk for the
disease. On the other hand, the SNP rs4075570 conferred
protection in the series studied.
Finally, Lidral [15] showed that rs7850258 G allele
associated with cleft lip, cleft palate, and hypothyroidism,
has significantly greater enhancer activity than the allele
associated with thyroid cancer (A); and Wokolorczyk
et al., [47] showed that the SNP rs6983267 could be a
good candidate multi-cancer susceptibility marker, once
this SNP is associated with a wide range of cancers
affecting the colon, prostate, breast, bladder, larynx,
lung, kidney, and the thyroid [47]. These are some
examples of the rapidly increasing number of studies
focused on identifying genetic variants associated with
TC predisposition and development.
An important challenge faced by molecular epidemio-
logical association studies of candidate disease-susceptibility
genes is to define variants that are functionally implicated in
the disease. In addition to identifying polymorphic genetic
variants and their possible association with diseases, it is
necessary to understand the functional relevance of these
SNPs. This is particularly urgent because the amount of
genomic information that is available greatly exceeds the
information about the function of variants that are pre-
sented in human disease studies [53]. Importantly, most of
the recent genetic studies only establish the statistical
associations of genetic markers and the disease, without
supporting evidence of functional relevance. In context of
predisposition to TC, new light is given on the molecular
mechanisms of genetic variants through advances in
molecular technologies.
As an example, the association of polymorphisms in
DNA repair genes XRCC1 (rs25487, rs1799782) and
XRCC3 (rs861539) with thyroid cancer risk and progres-
sion can be considered. As Yan and collaborators
showed, the XRCC1 variant can interact with the
XRCC3 variant to significantly increase differentiated
thyroid carcinoma (DTC) susceptibility [22]. Similarly, a
study to assess the role of polymorphisms in the LEP
(rs7799039 and rs2167270) and LEPR (rs1137101 and
rs1137100) genes in DTC susceptibility and their effect
Fig. 1 Associations between 9 SNPs and thyroid cancer susceptibility analyzed by the Forest plot. a All SNPs that show significant risk associated
with thyroid cancer development. b All SNPs that show significant protection against thyroid cancer development. The summary represents a
combination of SNPs that show risk or protection regarding cancer development
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on leptin levels showed that LEP polymorphisms modify
serum leptin concentrations in patients with DTC. Fur-
thermore, the polymorphisms rs7799039 and rs1137101 in-
crease the risk of DTC development, though they do not
correlate with tumor aggressiveness [16]. As another
example, supporting evidence of functional relevance was
presented by Ceolin and collaborators [19], who evaluated
the frequency of RET (REarranged during Transfection)
proto-oncogene 3’UTR variants (rs76759170 and rs3026785)
in Medullary Thyroid Carcinoma (MTC) patients. In silico
analysis indicated that these variants might affect the second-
ary structure of RET mRNA, suggesting that they might play
a role in the posttranscriptional control of RET transcripts.
In our study for molecular markers of predisposition
to TC, we assessed the allele and genotype frequency of
45 SNPs, including four of the aforementioned SNPs.
We observed that SNPs rs2910164 and rs965513, despite
being in HWE, did not show associated risk with TC for
the Brazilian population. Furthermore, SNPs rs6983267
and rs944289 were not in Hardy-Weinberg equilibrium
in our studied groups. As observed, the frequencies of
these particular SNPs differ from those observed for
European, American and Asian populations, where some
of these markers were associated with an increased risk
of developing TC. These results reinforce the concept
that the genetic constitution of a population, and the
contribution of ancestral roots, is an important and
influencing parameter in genetic association studies.
Other studies evaluated potential markers for predis-
position to thyroid cancer in larger sample sizes [10, 46].
These studies were performed in European populations,
but these kinds of studies were not previously performed
in a Brazilian population. Therefore, this pilot study pre-
sents a good opportunity to examine the feasibility of
our approach, exploring a novel panel of SNPs that could
potentially predict TC risk. We have thus first investigated
these SNPs in a pilot study with a plan to validate our
findings in a larger sample in the future. It is critical to
improve both our knowledge of thyroid cancer risk factors
and our knowledge of markers that predict aggressive
disease in order to reduce disease incidence and unneces-
sary treatments that result in undesirable side effects with
long-term financial and clinical impacts.
Conclusions
Of a total of 35 SNPs that were found in HWE in the
Brazilian population, logistic regression analysis of 7 SNPs
showed statistical significance when evaluated according
to the genetic model of inheritance. For the first time, our
results suggest that a new panel constituted of SNPs
rs3744962, rs258107, rs4075022, rs9943744, rs4075570,
rs17485896, and rs2651339 could represent predisposition
to TC development in the population of Rio Grande do
Norte. Furthermore, they may be considered suitable
molecular markers for early diagnosis of the disease.
These SNPs could be useful models to predict risk and for
genetic counseling in clinical practice, thus avoiding inva-
sive methods of analysis and often inconclusive diagnoses.
In addition, SNPs rs1461855 and rs2356508 might pos-
sibly be associated with a protective effect against TC
development. Nevertheless, complementary studies with a
larger patient population as well as a control group
composed of samples from the state of Rio Grande do
Norte should be conducted to confirm these results.
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